SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001654954-22-007809
Filing Date
2022-06-01
Accepted
2022-06-01 16:20:56
Documents
8
Period of Report
2022-07-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A drma_def14a.htm DEF 14A 529271
2 drma_def14aimg3.gif GRAPHIC 5089
3 drma_def14aimg4.jpg GRAPHIC 1256
4 drma_def14aimg5.jpg GRAPHIC 1066
5 drma_def14aimg6.jpg GRAPHIC 999
6 drma_def14aimg7.jpg GRAPHIC 1295
7 drma_pre14aimg1.jpg GRAPHIC 4871
8 drma_pre14aimg2.jpg GRAPHIC 4871
  Complete submission text file 0001654954-22-007809.txt   557971
Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Filer) CIK: 0001853816 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40739 | Film No.: 22987613
SIC: 2834 Pharmaceutical Preparations